JESSICA SCHMIDT: Open Payments
NPI 1073029740 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,626 in 103 payments from 23 companies in 2025. Trend: 2023 $1,112 · 2024 $1,326 · 2025 $1,626
Food & beverage: $1,451Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 37 | $312 |
| Amgen Inc. | 5 | $230 |
| ABBVIE INC. | 11 | $136 |
| Neurocrine BioSciences, Inc. | 5 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $90 |
| Corcept Therapeutics | 4 | $82 |
| Tandem Diabetes Care, Inc. | 6 | $77 |
| Novo Nordisk Inc | 4 | $71 |
| Dexcom, Inc. | 2 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
Products named: Omnipod, PROLIA, CRENESSITY, JARDIANCE, Korlym, t:slim X2 Insulin Pump with Control-IQ, FARXIGA, FREESTYLE LIBRE 3.
Industry payments across KS — which companies pay providers there.
